![Sten Dahlborg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sten Dahlborg
Directeur/Membre du Conseil chez ExScale Biospecimen Solutions AB
Profil
Sten Dahlborg currently works at ExScale Biospecimen Solutions AB, as Director.
Mr. Dahlborg received his graduate degree from Chalmers University of Technology.
Postes actifs de Sten Dahlborg
Sociétés | Poste | Début |
---|---|---|
ExScale Biospecimen Solutions AB
![]() ExScale Biospecimen Solutions AB BiotechnologyHealth Technology ExScale Biospecimen Solutions AB provides automated, next generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded tissue sections using paramagnetic beads. It specializes in processes and know-how for nucleic acid extraction from human tissue specimens. The firm's technology enables serial extraction of DNA and RNA from the same bio-specimen where the isolated nucleic acids are of optimal quality for next generation sequencing and other downstream applications. It offers ExScale NGEx kit which consists of plastic-ware, reagents packed into prefilled cartridges and a deparaffinisation reagent. The company was founded by Lucy Mathot and Carl Tobias Sjöblom in 2012 and is headquartered in Uppsala, Sweden. | Directeur/Membre du Conseil | - |
Formation de Sten Dahlborg
Chalmers University of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
ExScale Biospecimen Solutions AB
![]() ExScale Biospecimen Solutions AB BiotechnologyHealth Technology ExScale Biospecimen Solutions AB provides automated, next generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded tissue sections using paramagnetic beads. It specializes in processes and know-how for nucleic acid extraction from human tissue specimens. The firm's technology enables serial extraction of DNA and RNA from the same bio-specimen where the isolated nucleic acids are of optimal quality for next generation sequencing and other downstream applications. It offers ExScale NGEx kit which consists of plastic-ware, reagents packed into prefilled cartridges and a deparaffinisation reagent. The company was founded by Lucy Mathot and Carl Tobias Sjöblom in 2012 and is headquartered in Uppsala, Sweden. | Health Technology |